Normeg (Levetiracetam)

Levetiracetam, the active ingredient in Normeg, is an anticonvulsant presented as an oral formulation for oral use. It treats partial onset, myoclonic and generalized tonic‑clonic seizures in patients who require reliable seizure control across a range of ages.

GNH USA supplies Normeg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is used in the management of several seizure types within the epileptic disorder spectrum.

Partial onset seizures: reduces the frequency of focal seizures and improves daily functioning. Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with juvenile myoclonic epilepsy. Generalized tonic‑clonic seizures: helps prevent loss of consciousness and convulsive episodes in generalized epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: persistent tiredness not relieved by rest. - Headache: mild to moderate cranial pain. - Irritability: increased emotional lability. - Nausea: feeling of queasiness or upset stomach. - Somnolence: tendency to fall asleep during the day.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or aggressive behavior. - Blood disorders: unexplained bruising or bleeding. - Liver enzyme elevation: abnormal liver function tests. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Seizure worsening: paradoxical increase in seizure frequency.

Before initiating therapy, clinicians should assess individual risk factors and monitor patients regularly.

Renal function: adjust dose in patients with impaired clearance. Psychiatric history: monitor for mood alterations or suicidal ideation. Concomitant CNS depressants: avoid excessive sedation when combined. Pregnancy and lactation: evaluate risk‑benefit ratio; data are limited. Elderly patients: start at lower dose and titrate cautiously. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Levetiracetam has a relatively low potential for drug‑drug interactions, but certain combinations require attention.

Major Interactions (Avoid): - Live vaccines: may reduce vaccine efficacy; avoid concurrent administration. - Strong enzyme inducers (e.g., carbamazepine, phenytoin): can lower levetiracetam plasma levels.

Moderate Interactions (Monitor Closely): - Sedative agents (e.g., benzodiazepines, alcohol): may increase central nervous system depression. - Antidepressants (e.g., SSRIs): monitor for heightened irritability or mood changes. - Antihypertensives: observe for potential blood pressure alterations. - Antacids containing aluminum or magnesium: may affect absorption if taken simultaneously.